Listonstreetpulse.com announces that Arrayit Corporation (OTC: ARYC) will be presented in a series of one-on-one meetings at the National Investment Banker Association (NIBA) Meeting, which is being held at the Roosevelt Hotel at Madison Avenue in midtown Manhattan in New York City. The NIBA Meeting began today and will last until Wednesday, September 18, 2013. ARYC will be presented by event sponsor Crucible Capital Group.
The NIBA Meeting offers a unique opportunity for broker dealers, investment bankers, fund managers, and capital market service providers to make valuable industry connections while gaining new perspectives on critical market challenges, issues and trends redefining today’s dynamic and ever-evolving capital formation markets.
Chuck Moore, CEO of Crucible Capital, says, “In 28 years in the business the just completed June 2013 NIBA conference in NYC was the best conference I have ever attended; from the excellent, courteous, knowledgeable, efficient and competent staff; to the precision scheduling, and excellent quality companies, and off the charts networking opportunities.”
Mr. Moore will be seeking $10 million in growth capital on behalf of ARYC. The growth capital will help ARYC in expanding its core life sciences tools business and complete FDA approval of the Arrayit OvaDx® Pre-Symptomatic Test for Ovarian Cancer and the Arrayit PDx™ Pre-Symptomatic Test for Parkinson’s Disease. In the past 90 calendar days, ARYC shares have gained nearly 320%.
To read more about ARYC and subscribe to a monthly update, CEO interview etc, please click here – http://www.listonstreetpulse.com/tag/ARYC/
About Arrayit Corporation
Arrayit Corporation is a Sunnyvale, California-based company leading and empowering the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development, and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. The company’s innovative products and services help scientists and clinicians explore the human genome as well as the genomes of plants and animals. Arrayit’s products are used by every major research center in the world.
About Liston Street Pulse
Liston Street Pulse is a leading provider of financial research. The company has significant expertise in U.S. listed small cap and micro-cap stocks. Over the years, Liston Street Pulse’s original and unbiased analysis has helped the investor community immensely.
